Urinary podocalyxin levels were associated with urinary albumin levels among patients with diabetes

M. Shoji, K. Kobayashi, M. Takemoto, Y. Sato, K. Yokote

研究成果: Article

12 引用 (Scopus)

抜粋

Diabetic nephropathy has dramatically increased worldwide. In this study, we measured urinary podocalyxin in 240 patients with diabetes. The relationship between urinary podocalyxin and clinical parameters and the effects of dipeptidyl peptidase-4 inhibitors (DPP4i) and alpha-glucosidase inhibitor (a-GI) on urinary podocalyxin levels were examined. Urinary podocalyxin levels were significantly higher in patients with microalbuminuria than in those with normoalbuminuria. Urinary podocalyxin levels were also significantly related to albumin-to-creatinine ratio. Neither DPP4i nor α-GI ameliorated the increase in urinary podocalyxin levels. Our results indicated that urinary podocalyxin will be not only an early marker but also a treatment target for DN.

元の言語English
ページ(範囲)164-167
ページ数4
ジャーナルBiomarkers
21
発行部数2
DOI
出版物ステータスPublished - 2016 2 17

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Health, Toxicology and Mutagenesis

フィンガープリント Urinary podocalyxin levels were associated with urinary albumin levels among patients with diabetes' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用